<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39410604</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Diagnostic Accuracy of the LabTurbo QuadAIO Common Flu Assay for Detecting Influenza A Virus, Influenza B Virus, RSV, and SARS-CoV-2.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2200</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14192200</ELocationID><Abstract><AbstractText><b>Background:</b> The coronavirus disease 2019 (COVID-19) pandemic has highlighted the urgent need for rapid and accurate diagnostic tools for upper respiratory tract infections (URTIs). Nucleic acid amplification tests (NAATs) have transformed URTI diagnostics by enabling the rapid detection of multiple pathogens simultaneously, thereby improving patient management and infection control. This study aimed to evaluate the diagnostic accuracy of the LabTurbo QuadAIO Common Flu Assay compared to that of the Xpert Xpress CoV-2/Flu/RSV Plus Assay for detecting SARS-CoV-2, Influenza A, Influenza B, and respiratory syncytial virus (RSV). <b>Methods:</b> A retrospective diagnostic accuracy study was conducted using nasopharyngeal samples from patients. Samples were tested using the LabTurbo QuadAIO Common Flu Assay and the comparator Xpert Xpress CoV-2/Flu/RSV Plus Assay. Positive and negative percent agreements (PPA and NPA) were calculated. <b>Results:</b> The LabTurbo Assay demonstrated a PPA of 100% and an NPA of 100% for SARS-CoV-2, Influenza A, and Influenza B, whereas it showed a PPA of 100% and an NPA of 98.3% for RSV. <b>Conclusions:</b> The LabTurbo QuadAIO Assay exhibited high diagnostic accuracy for detecting multiple respiratory pathogens, including SARS-CoV-2, Influenza A, Influenza B, and RSV. Despite the slight discrepancy in the NPA for RSV, the overall performance of the LabTurbo Assay supports its integration into routine diagnostic workflows to enhance patient management and infection control.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Chi-Sheng</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0009-0007-2948-2049</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jian</LastName><ForeName>Ming-Jr</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-4902-4447</Identifier><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tai-Han</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0002-6100-3120</Identifier><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Hsing-Yi</ForeName><Initials>HY</Initials><Identifier Source="ORCID">0000-0002-7870-8354</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Cherng-Lih</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Po-Shiuan</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0002-3402-9851</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Medical Science, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Hung-Sheng</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0002-4831-1866</Identifier><AffiliationInfo><Affiliation>Division of Clinical Pathology, Department of Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TSGH-D-113105</GrantID><Agency>Tri-Service General Hospital</Agency><Country /></Grant><Grant><GrantID>TSGH-D-113106</GrantID><Agency>Tri-Service General Hospital</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Influenza A</Keyword><Keyword MajorTopicYN="N">Influenza B</Keyword><Keyword MajorTopicYN="N">LabTurbo QuadAIO</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diagnostic accuracy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funder had no role in the study design, data collection, interpretation, or decision to submit this work for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39410604</ArticleId><ArticleId IdType="pmc">PMC11475264</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14192200</ArticleId><ArticleId IdType="pii">diagnostics14192200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stukovnik Z., Bren U. Recent Developments in Electrochemical-Impedimetric Biosensors for Virus Detection. Int. J. Mol. Sci. 2022;23:15922. doi: 10.3390/ijms232415922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415922</ArticleId><ArticleId IdType="pmc">PMC9788240</ArticleId><ArticleId IdType="pubmed">36555560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Parihar A., Panda U., Parihar D.S. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution. ACS Appl. Biol. Mater. 2022;5:2046–2068. doi: 10.1021/acsabm.1c01320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.1c01320</ArticleId><ArticleId IdType="pubmed">35473316</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendish N.J., Poole S., Naidu V.V., Mansbridge C.T., Norton N.J., Wheeler H., Presland L., Kidd S., Cortes N.J., Borca F., et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): A prospective, interventional, non-randomised, controlled study. Lancet Respir. Med. 2020;8:1192–1200. doi: 10.1016/S2213-2600(20)30454-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30454-9</ArticleId><ArticleId IdType="pmc">PMC7544498</ArticleId><ArticleId IdType="pubmed">33038974</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Respiratory M. Patterns of respiratory infections after COVID-19. Lancet Respir. Med. 2024;12:1. doi: 10.1016/S2213-2600(23)00472-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00472-1</ArticleId><ArticleId IdType="pubmed">38101434</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidmann M.D., Green D.A., Berry G.J., Wu F. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV. Front. Cell Infect. Microbiol. 2023;13:1208235. doi: 10.3389/fcimb.2023.1208235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1208235</ArticleId><ArticleId IdType="pmc">PMC10302716</ArticleId><ArticleId IdType="pubmed">37389220</ArticleId></ArticleIdList></Reference><Reference><Citation>Stromer A., Rose R., Schafer M., Schon F., Vollersen A., Lorentz T., Fickenscher H., Krumbholz A. Performance of a Point-of-Care Test for the Rapid Detection of SARS-CoV-2 Antigen. Microorganisms. 2020;9:58. doi: 10.3390/microorganisms9010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9010058</ArticleId><ArticleId IdType="pmc">PMC7823488</ArticleId><ArticleId IdType="pubmed">33379279</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q., Sun X., Dai Z., Gao Y., Gong X., Zhou B., Wu J., Wen W. Point-of-care testing detection methods for COVID-19. Lab. Chip. 2021;21:1634–1660. doi: 10.1039/D0LC01156H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0LC01156H</ArticleId><ArticleId IdType="pubmed">33705507</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson K.E., Azar M.M., Banerjee R., Chou A., Colgrove R.C., Ginocchio C.C., Hayden M.K., Holodiny M., Jain S., Koo S., et al. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations from the IDSA’s Diagnostics Committee. Clin. Infect. Dis. 2020;71:2744–2751. doi: 10.1093/cid/ciaa508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa508</ArticleId><ArticleId IdType="pmc">PMC7454374</ArticleId><ArticleId IdType="pubmed">32369578</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.S., Tsai C.L., Chang J., Hsu T.C., Lin S., Lee C.C. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: Systematic review and meta-analysis. Clin. Microbiol. Infect. 2018;24:1055–1063. doi: 10.1016/j.cmi.2017.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2017.11.018</ArticleId><ArticleId IdType="pmc">PMC7128951</ArticleId><ArticleId IdType="pubmed">29208560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasidharan A., Selvarangan R., Konrad K., Faron M.L., Shakir S.M., Hillyard D., McCall R.K., McHardy I.H., Goldberg D.C., Dunn J.J., et al. Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals. J. Clin. Microbiol. 2023;61:e0082723. doi: 10.1128/jcm.00827-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00827-23</ArticleId><ArticleId IdType="pmc">PMC10662375</ArticleId><ArticleId IdType="pubmed">37902331</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukli N., Flamand C., Chea K.L., Heng L., Keo S., Sour K., In S., Chhim P., Chhor B., Kruy L., et al. One Assay to Test Them All: Comparing Multiplex Assays for Expansion of Respiratory Virus Surveillance. medRxiv. 2023 doi: 10.1101/2023.01.19.23284806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.19.23284806</ArticleId><ArticleId IdType="pmc">PMC10165998</ArticleId><ArticleId IdType="pubmed">37168265</ArticleId></ArticleIdList></Reference><Reference><Citation>Audi A., AlIbrahim M., Kaddoura M., Hijazi G., Yassine H.M., Zaraket H. Seasonality of Respiratory Viral Infections: Will COVID-19 Follow Suit? Front. Public Health. 2020;8:567184. doi: 10.3389/fpubh.2020.567184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.567184</ArticleId><ArticleId IdType="pmc">PMC7522168</ArticleId><ArticleId IdType="pubmed">33042956</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman Z., Li M., Wang X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front. Immunol. 2020;11:552909. doi: 10.3389/fimmu.2020.552909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.552909</ArticleId><ArticleId IdType="pmc">PMC7516028</ArticleId><ArticleId IdType="pubmed">33013925</ArticleId></ArticleIdList></Reference><Reference><Citation>Havasi A., Visan S., Cainap C., Cainap S.S., Mihaila A.A., Pop L.A. Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences—A Focus on Diagnosis. Front. Microbiol. 2022;13:908525. doi: 10.3389/fmicb.2022.908525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.908525</ArticleId><ArticleId IdType="pmc">PMC9251468</ArticleId><ArticleId IdType="pubmed">35794916</ArticleId></ArticleIdList></Reference><Reference><Citation>Alotaibi B.S., Tantry B.A., Bandy A., Ahmad R., Khursheed S.Q., Ahmad A., Hakami M.A., Shah N.N. Simultaneous Detection of Influenza A/B, Respiratory Syncytial Virus, and SARS-CoV-2 in Nasopharyngeal Swabs by One-Tube Multiplex Reverse Transcription Polymerase Chain Reaction. Trop. Med. Infect. Dis. 2023;8:326. doi: 10.3390/tropicalmed8060326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8060326</ArticleId><ArticleId IdType="pmc">PMC10305207</ArticleId><ArticleId IdType="pubmed">37368744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H.Y., Jian M.J., Chang C.K., Lin J.C., Yeh K.M., Chen C.W., Chiu S.K., Wang Y.H., Liao S.J., Li S.Y., et al. Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system. Emerg. Microbes Infect. 2021;10:161–166. doi: 10.1080/22221751.2021.1873073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1873073</ArticleId><ArticleId IdType="pmc">PMC7832498</ArticleId><ArticleId IdType="pubmed">33410371</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung E.C., Chow V.C., Lee M.K., Tang K.P., Li D.K., Lai R.W. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens. J. Clin. Microbiol. 2021;59:4. doi: 10.1128/JCM.02965-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02965-20</ArticleId><ArticleId IdType="pmc">PMC8092745</ArticleId><ArticleId IdType="pubmed">33436456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li G., Zhao J., Li Y., Ai Y. An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2. Front. Med. 2020;7:571709. doi: 10.3389/fmed.2020.571709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.571709</ArticleId><ArticleId IdType="pmc">PMC7848129</ArticleId><ArticleId IdType="pubmed">33537322</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendish N.J., Malachira A.K., Clark T.W. Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: A pragmatic randomised controlled trial protocol (ResPOC) BMC Infect. Dis. 2017;17:128. doi: 10.1186/s12879-017-2219-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2219-x</ArticleId><ArticleId IdType="pmc">PMC5294894</ArticleId><ArticleId IdType="pubmed">28166743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Wang L., Deng X., Liang R., Su M., He C., Hu L., Su Y., Ren J., Yu F., et al. Recent advances in the detection of respiratory virus infection in humans. J. Med. Virol. 2020;92:408–417. doi: 10.1002/jmv.25674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25674</ArticleId><ArticleId IdType="pmc">PMC7166954</ArticleId><ArticleId IdType="pubmed">31944312</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar M.M., Landry M.L. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: A Paradigm Shift to Molecular Tests. J. Clin. Microbiol. 2018;56:7. doi: 10.1128/JCM.00367-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00367-18</ArticleId><ArticleId IdType="pmc">PMC6018333</ArticleId><ArticleId IdType="pubmed">29695519</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassedy A., Parle-McDermott A., O’Kennedy R. Virus Detection: A Review of the Current and Emerging Molecular and Immunological Methods. Front. Mol. Biosci. 2021;8:637559. doi: 10.3389/fmolb.2021.637559.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.637559</ArticleId><ArticleId IdType="pmc">PMC8093571</ArticleId><ArticleId IdType="pubmed">33959631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>